Skip to main content
Premium Trial:

Request an Annual Quote

Nucleic Acid Extraction System From Systaaq Diagnostic CE Marked

NEW YORK – Systaaq Diagnostic Products announced today that its automated nucleic acid extraction system, SuperExtract 32, and viral nucleic acid extraction kit for in vitro diagnostic use have been CE-IVD marked.

The product is now available for use by hospitals and health systems that recognize the designation.

The Manassas, Virginia-based company, which develops molecular diagnostic assays for the life science and diagnostics markets, said that SuperExtract 32 with the SuperExtract Viral Mag NA Purification kit provides high-quality purification of hepatitis and HIV viral nucleic acid from plasma and serum for viral detection and quantification. 

It added that its HBV and HCV tests recently also received CE marking, and the products will be launched soon in Europe, Asia, and South America.  

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.